LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 111 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,596,692 | -52.4% | 2,382,286 | 0.0% | 0.20% | -51.7% |
| Q2 2023 | $5,455,435 | -5.8% | 2,382,286 | 0.0% | 0.42% | +4.0% |
| Q1 2023 | $5,788,955 | +27.2% | 2,382,286 | 0.0% | 0.40% | +56.2% |
| Q4 2022 | $4,550,166 | -20.4% | 2,382,286 | 0.0% | 0.26% | -10.2% |
| Q3 2022 | $5,717,000 | +29.0% | 2,382,286 | 0.0% | 0.28% | +25.0% |
| Q2 2022 | $4,431,000 | -11.0% | 2,382,286 | 0.0% | 0.23% | +58.3% |
| Q1 2022 | $4,979,000 | -47.0% | 2,382,286 | 0.0% | 0.14% | -24.2% |
| Q4 2021 | $9,386,000 | -18.1% | 2,382,286 | 0.0% | 0.19% | +39.7% |
| Q3 2021 | $11,459,000 | +4.8% | 2,382,286 | 0.0% | 0.14% | -4.2% |
| Q2 2021 | $10,935,000 | -21.8% | 2,382,286 | 0.0% | 0.14% | -54.8% |
| Q1 2021 | $13,984,000 | +71.6% | 2,382,286 | 0.0% | 0.31% | +46.0% |
| Q4 2020 | $8,147,000 | +137.5% | 2,382,286 | 0.0% | 0.22% | +48.3% |
| Q3 2020 | $3,430,000 | -27.8% | 2,382,286 | 0.0% | 0.14% | -24.1% |
| Q2 2020 | $4,753,000 | +2.3% | 2,382,286 | 0.0% | 0.19% | -21.4% |
| Q1 2020 | $4,646,000 | -53.0% | 2,382,286 | 0.0% | 0.24% | -48.0% |
| Q4 2019 | $9,886,000 | +37.9% | 2,382,286 | 0.0% | 0.47% | -21.4% |
| Q3 2019 | $7,171,000 | -52.1% | 2,382,286 | 0.0% | 0.59% | -43.4% |
| Q2 2019 | $14,985,000 | +13.1% | 2,382,286 | 0.0% | 1.05% | +52.6% |
| Q1 2019 | $13,246,000 | -16.3% | 2,382,286 | 0.0% | 0.69% | +9.7% |
| Q4 2018 | $15,818,000 | -37.8% | 2,382,286 | 0.0% | 0.63% | -42.8% |
| Q3 2018 | $25,419,000 | -11.1% | 2,382,286 | 0.0% | 1.10% | -18.1% |
| Q2 2018 | $28,587,000 | +40.0% | 2,382,286 | 0.0% | 1.34% | +47.5% |
| Q1 2018 | $20,416,000 | -13.3% | 2,382,286 | 0.0% | 0.91% | -6.9% |
| Q4 2017 | $23,537,000 | -19.6% | 2,382,286 | 0.0% | 0.98% | -4.9% |
| Q3 2017 | $29,278,000 | -25.3% | 2,382,286 | 0.0% | 1.02% | -28.1% |
| Q2 2017 | $39,189,000 | +14.7% | 2,382,286 | 0.0% | 1.43% | +20.0% |
| Q1 2017 | $34,162,000 | +3.7% | 2,382,286 | 0.0% | 1.19% | -9.3% |
| Q4 2016 | $32,947,000 | -23.5% | 2,382,286 | 0.0% | 1.31% | -32.2% |
| Q3 2016 | $43,048,000 | +25.9% | 2,382,286 | 0.0% | 1.93% | +8.9% |
| Q2 2016 | $34,186,000 | +20.1% | 2,382,286 | 0.0% | 1.77% | -6.2% |
| Q1 2016 | $28,468,000 | -10.2% | 2,382,286 | 0.0% | 1.89% | -6.3% |
| Q4 2015 | $31,708,000 | – | 2,382,286 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |